- 4-Week Delivery: World’s fastest custom mouse model development.
- TurboMice™ Tech: Proprietary high-efficiency gene-editing platform.
- Full Capabilities: Expert conditional knockouts, knock-ins, and humanized models.
- Validated Quality: Guaranteed high precision and model viability.
Plaur (uPAR) KO Mouse Model
| Strain Name | Plaur (uPAR) KO Mouse Model (M10046) |
|---|---|
| Editing Type | Knockout |
| Gene Name | Plaur (plasminogen activator, urokinase receptor; protein: uPAR / CD87; human ortholog PLAUR) |
| Gene Synonyms | Cd87; uPAR; u-PAR |
| Strain Background | C57BL/6N |
| NCBI No. | Gene ID 18793 |

- Tissue fibrosis — Interrogate uPAR in pulmonary, renal and cardiac fibrosis: plasminogen activation, ECM disassembly, mesenchymal/myofibroblast differentiation, and cell-matrix adhesion. Lung shows the highest adult expression (RPKM 24.3), making it the natural entry tissue.
- Tumor invasion & metastasis — Assess uPAR-dependent invasion, EMT, and uPA/uPAR-driven proliferation; evaluate therapeutic potential of blocking the uPA–uPAR axis in metastasis.
- Renal suPAR–podocyte axis — suPAR signals through formyl peptide receptor/β-arrestin-1 and αVβ3-integrin on podocytes, rapidly altering podocyte function and driving proteinuria—a ready-made glomerular readout.
- Angiogenesis, inflammation & repair — Study uPAR in angiogenic and prosurvival programs of mesenchymal stromal cells, inflammatory signaling (including TLR7-dependent macrophage efferocytosis), and tissue remodeling.
- Clinical translation — Human PLAUR is annotated by NCBI as implicated in rheumatoid arthritis; the gene carries 515 PubMed citations and 103 GeneRIFs, a thick literature base for anti-fibrotic and anti-metastatic efficacy studies.
This model carries a targeted knockout of the Plaur gene, which encodes uPAR (urokinase plasminogen activator receptor, also CD87), a GPI-anchored membrane protein that binds uPA with high affinity and concentrates plasminogen activation at the cell surface. uPAR couples pericellular proteolysis to adhesion and signaling—through integrins, the EGFR pathway, and serine-protease complexes—and thereby governs extracellular matrix disassembly, cell migration, mesenchymal differentiation, and angiogenic and prosurvival programs. Its soluble ectodomain (suPAR) circulates and acts on podocytes and immune cells. Removing uPAR function provides an in vivo system for dissecting this receptor’s contribution to fibrotic remodeling, tumor invasion, and vascular biology.
- Lung-highest, broad expression — Broad adult expression across 17 tissues with lung adult at RPKM 24.3 and spleen at 16.2, directly supporting pulmonary and immune-focused study designs.
- Mechanistically anchored ECM arm — GO annotates plasminogen activation, positive regulation of extracellular matrix disassembly, cell-matrix adhesion, and the urokinase plasminogen activator signaling pathway at this locus.
- A readout phenotype, not just a genotype — uPAR deficiency in mice is documented to produce perivascular fibrosis in the heart, so the strain carries an observable endpoint out of the box.
- Renal suPAR–podocyte entry point — suPAR acts on podocyte formyl peptide receptors, β-arrestin-1, and αVβ3-integrin to alter podocyte function and mediate proteinuria, extending the model into glomerular disease.
- Clinically linked ortholog with deep literature — Human PLAUR is NCBI-annotated as implicated in rheumatoid arthritis; 515 citations and 103 GeneRIFs underpin efficacy evaluation for anti-metastatic and anti-fibrotic programs.

FAQ
Game-changing benefits?
While competitors highlight germline efficiency gains, shorter timelines and enhanced 3Rs animal welfare benefits for their technologies, these are merely incremental improvements over traditional approaches. In sharp contrast, our proprietary technology delivers fully pure, homogeneous lineages—every single cell of the mice is derived exclusively from totipotent ES cells, with guaranteed 100% germline transmission efficiency. To experience these unparalleled benefits firsthand, enquire about your custom mouse model project with us or order embryos for in-house validation at your facility.
How much for a project assessment?
•Free initial design proposal with zero obligations.
•Request a free quote!
Who owns the mouse lP? Do l need a licence from Mingceler?
All model generation projects of Mingceler operate under a fee-for-service framework.
IP Ownership: All intellectual property rights related to custom mouse models, including derived organs, tissues, cells, and biological materials, are the sole and exclusive property of the Client.
Third-Party Transfer Permission: The Client may independently decide to retain, utilize, or commercialize their custom models project materials (e.g., targeting vectors, ES cells, mouse lines) without the need for prior consent from Mingceler.
Licensing Exemption: The Client has full autonomy over all uses of the custom models or their derivatives, including but not limited to commercialization, distribution to third parties, and publication involving model data. No written license from Mingceler is required for such uses.
